Published in Healthcare Mergers, Acquisitions and Ventures Week, May 5th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Inflazyme Pharmaceuticals.
Report 1: Inflazyme Pharmaceuticals, Ltd., (IZP) announced that it has successfully completed its previously announced nonbrokered unit offering with the issue of 17.6 million units at $0.17 per unit for gross proceeds of CDN$3 million.
Each unit comprises 1 common share of Inflazyme stock and one-half of 1 share purchase warrant. Each whole warrant has a 12-month term from the date of closing and an exercise price of $0.29 per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.